• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

First Egyptian patient with STING-associated vasculopathy with onset in infancy.

作者信息

Shoman W, El Chazli Y, ElSawy I, Aróstegui J I

机构信息

a Pediatric Immunology/Rheumatology Unit , Alexandria University Children's Hospital , Alexandria , Egypt.

b Pediatric Hematology/Oncology Unit , Alexandria University Children's Hospital , Alexandria , Egypt.

出版信息

Scand J Rheumatol. 2019 Jul;48(4):338-339. doi: 10.1080/03009742.2018.1550212. Epub 2019 Feb 22.

DOI:10.1080/03009742.2018.1550212
PMID:30794020
Abstract
摘要

相似文献

1
First Egyptian patient with STING-associated vasculopathy with onset in infancy.首例发病于婴儿期的与STING相关的血管病埃及患者。
Scand J Rheumatol. 2019 Jul;48(4):338-339. doi: 10.1080/03009742.2018.1550212. Epub 2019 Feb 22.
2
Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy.婴儿期起病的与干扰素基因刺激蛋白（STING）相关血管病所致间质性肺疾病
Am J Respir Crit Care Med. 2016 Sep 1;194(5):639-42. doi: 10.1164/rccm.201510-2102LE.
3
Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173.托法替布可缓解由TMEM173基因的2个新发变异导致的婴儿期起病的干扰素基因刺激物（STING）相关血管病的症状。
J Allergy Clin Immunol. 2017 Apr;139(4):1396-1399.e12. doi: 10.1016/j.jaci.2016.10.030. Epub 2016 Dec 29.
4
STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib.婴儿期起病的 STING 相关性血管病伴新型临床特征，托法替尼治疗反应不佳：三例报告
J Clin Immunol. 2020 Jan;40(1):114-122. doi: 10.1007/s10875-019-00690-9. Epub 2019 Nov 8.
5
A patient with stimulator of interferon genes-associated vasculopathy with onset in infancy without skin vasculopathy.一名患有干扰素基因刺激物相关血管病且发病于婴儿期但无皮肤血管病的患者。
Rheumatology (Oxford). 2020 Apr 1;59(4):905-907. doi: 10.1093/rheumatology/kez444.
6
A novel STING variant triggers endothelial toxicity and SAVI disease.一种新型 STING 变体引发血管内皮毒性和 SAVI 疾病。
J Exp Med. 2024 Sep 2;221(9). doi: 10.1084/jem.20232167. Epub 2024 Jul 2.
7
Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey.巴利昔替尼治疗婴儿期起病的 STING 相关性血管病：土耳其的一个代表性病例。
Clin Immunol. 2020 Mar;212:108273. doi: 10.1016/j.clim.2019.108273. Epub 2019 Oct 15.
8
A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI).一种新型的STING1变体导致一种隐性形式的婴儿期起病的STING相关血管病（SAVI）。
J Allergy Clin Immunol. 2020 Nov;146(5):1204-1208.e6. doi: 10.1016/j.jaci.2020.06.032. Epub 2020 Jul 13.
9
STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.婴儿期起病的STING相关血管病（SAVI）伴皮肤损害。
Pediatr Dermatol. 2024 Sep-Oct;41(5):893-896. doi: 10.1111/pde.15620. Epub 2024 Apr 29.
10
Human induced pluripotent stem cells generated from STING-associated vasculopathy with onset in infancy (SAVI) patients with a heterozygous mutation in the STING gene.由 STING 相关血管病伴婴儿期起病（SAVI）患者的 STING 基因杂合突变诱导产生的人多能干细胞。
Stem Cell Res. 2022 Dec;65:102974. doi: 10.1016/j.scr.2022.102974. Epub 2022 Nov 14.

引用本文的文献

1
STING-associated vasculopathy with onset in infancy: a familial case series report and literature review.婴儿期起病的STING相关性血管病：一项家族性病例系列报告及文献综述
Ann Transl Med. 2021 Jan;9(2):176. doi: 10.21037/atm-20-6198.
2
Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Systematic Review of Case Reports.婴儿期起病的干扰素基因刺激因子相关血管病：病例报告的系统评价
Front Pediatr. 2020 Dec 17;8:577918. doi: 10.3389/fped.2020.577918. eCollection 2020.
3
STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib.
婴儿期起病的 STING 相关性血管病伴新型临床特征，托法替尼治疗反应不佳：三例报告
J Clin Immunol. 2020 Jan;40(1):114-122. doi: 10.1007/s10875-019-00690-9. Epub 2019 Nov 8.